Browse diseases

…Introduction The global burden of liver cirrhosis continues to rise and NICE recommends 6-monthly hepatocellular …

… missing variables. Bradley et al developed a BN on survival in pancreatic ductal adenocarcinoma and evaluated the impact of at least two missing variables on t…

…nd reduced CPEB4 expression has been associated with aggressive HCC and poor outcome. However, its role in tumour vascular plastici…

…k in the progression from chronic liver injury to cirrhosis and hepatocellular carcinoma (HCC). Activated hepatic stellate cells (HSCs) play a central r…

…Background Hepatocellular carcinoma (HCC), one of the most prevalent cancers worldwide, has a high …

…Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality worldwide. Wh…

… issues regarding the implementation of non-invasive test-based hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…

…SM) ≥20 kPa (or LSM ≥15 kPa in the two-step algorithm)—to guide hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…

…also shared their data from 4386 patients with inactive chronic hepatitis B (CHB), which showed similarities with our findings.1…

…Background The hepatocellular carcinoma (HCC) immune microenvironment is heavily influenced by immunosu…

…Background Patients with early-stage to intermediate-stage hepatocellular carcinoma (HCC) face a high risk of recurrence after transarterial chemoe…

…erogeneity; Genetic deletion of CXCR1 overcome NK exhaustion in Hepatocellular Carcinoma; Anti-CXCR1 therapy inhibits tumor growth in combination with P…